Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial (Q35555303)
Jump to navigation
Jump to search
scientific article published on 5 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial |
scientific article published on 5 August 2011 |
Statements
1 reference
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial (English)
1 reference
A J Zurita
1 reference
D J George
1 reference
N D Shore
1 reference
G Liu
1 reference
G Wilding
1 reference
T E Hutson
1 reference
M Kozloff
1 reference
P Mathew
1 reference
C S Harmon
1 reference
S L Wang
1 reference
I Chen
1 reference
E Chow Maneval
1 reference
C J Logothetis
1 reference
5 August 2011
1 reference
1 reference
23
1 reference
3
1 reference
688-694
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference